Karen Sims, M.D., Ph.D.

Former Chief Medical OfficeratArbutus Biopharma· In proxies 2023–2024

Pay in FY2024Arbutus Biopharma stock +30.8% the same year

Karen Sims, M.D., Ph.D. was paid $1.7M in FY2024 (Dec). Arbutus Biopharma stock rose 30.8% that year.

Pay$100 in the stock at the end of FY22 → $140

Pay is from the Summary Compensation Table of each Arbutus Biopharma proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

Arbutus BiopharmaPublic company · 3 yr
- Former Chief Medical Officer2023 – Present · 3 yrStock in role +85%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSV Download PNG How to use our data

Two people shown as one, or a wrong number?